/
Precigen, Inc.
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.
Mentions
1 mention · latest on 5 Apr 2026
See which tracked investors hold Precigen, Inc. →Ownership and position changes on OwnershipTrace